Date: July 23, 2026
ESOP / ESAR Grants
Cipla Limited has made grants under two employee benefit schemes in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021:
- Under ESOS 2013-A Scheme: Granted 5,530 stock options with an exercise price of ₹2 per stock option. These options have a vesting period of 2 years from the grant date (July 23, 2026) and an exercise period of 5 years from the vesting date.
- Under ESAR 2021 Scheme: Granted 19,179 Employee Stock Appreciation Rights (ESARs) with an exercise price of ₹2 per equity share. These ESARs have a 3-year graded vesting schedule and an exercise period of 5 years from the vesting date.
Board Meeting Outcomes
The Board meeting commenced on July 23, 2026, at 9:15 AM IST and concluded at 1:00 PM IST. The primary outcome was the approval of the aforementioned grants under the company's employee benefit schemes.
Other Operational / Legal / Strategic Disclosures
The disclosure was formally submitted to BSE Limited and the National Stock Exchange of India Limited for record. The communication was digitally signed by Rajendra Chopra, Company Secretary, on July 23, 2026, at 13:22:27 IST.